1. Home
  2. NWGL vs NRXP Comparison

NWGL vs NRXP Comparison

Compare NWGL & NRXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NWGL
  • NRXP
  • Stock Information
  • Founded
  • NWGL 2008
  • NRXP 2015
  • Country
  • NWGL Macau
  • NRXP United States
  • Employees
  • NWGL N/A
  • NRXP N/A
  • Industry
  • NWGL
  • NRXP Biotechnology: Pharmaceutical Preparations
  • Sector
  • NWGL
  • NRXP Health Care
  • Exchange
  • NWGL Nasdaq
  • NRXP Nasdaq
  • Market Cap
  • NWGL 26.2M
  • NRXP 58.5M
  • IPO Year
  • NWGL 2023
  • NRXP N/A
  • Fundamental
  • Price
  • NWGL $1.07
  • NRXP $2.81
  • Analyst Decision
  • NWGL
  • NRXP Strong Buy
  • Analyst Count
  • NWGL 0
  • NRXP 4
  • Target Price
  • NWGL N/A
  • NRXP $28.50
  • AVG Volume (30 Days)
  • NWGL 41.1K
  • NRXP 134.9K
  • Earning Date
  • NWGL 08-12-2025
  • NRXP 08-13-2025
  • Dividend Yield
  • NWGL N/A
  • NRXP N/A
  • EPS Growth
  • NWGL N/A
  • NRXP N/A
  • EPS
  • NWGL N/A
  • NRXP N/A
  • Revenue
  • NWGL $21,539,347.00
  • NRXP N/A
  • Revenue This Year
  • NWGL N/A
  • NRXP N/A
  • Revenue Next Year
  • NWGL N/A
  • NRXP $230.95
  • P/E Ratio
  • NWGL N/A
  • NRXP N/A
  • Revenue Growth
  • NWGL N/A
  • NRXP N/A
  • 52 Week Low
  • NWGL $0.91
  • NRXP $1.10
  • 52 Week High
  • NWGL $6.61
  • NRXP $6.01
  • Technical
  • Relative Strength Index (RSI)
  • NWGL 46.73
  • NRXP 35.57
  • Support Level
  • NWGL $1.01
  • NRXP $2.89
  • Resistance Level
  • NWGL $1.08
  • NRXP $3.15
  • Average True Range (ATR)
  • NWGL 0.04
  • NRXP 0.14
  • MACD
  • NWGL 0.03
  • NRXP -0.04
  • Stochastic Oscillator
  • NWGL 90.00
  • NRXP 7.27

About NWGL Nature Wood Group Limited

Nature Wood Group Ltd is a vertically-integrated forestry company that focuses on FSC business operations. It produces various products, including logs, decking, flooring, sawn timber, recycled charcoal, synthesized charcoal, machine-made charcoal, and essential oils. The Group owns natural forest concessions and cutting rights for exploiting timbers on parcels of land in Peru. The Group is organized into two operating divisions; Direct Purchase and Original Design Manufacturer (ODM) Services, and Manufacturing segments. The Direct Purchase and ODM Segment that derives the majority of revenue engages in the business of sourcing live wood and owning designed designs on wood products for sales to end customers. Geographically, the company generates a majority of its revenue from China.

About NRXP NRX Pharmaceuticals Inc.

NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.

Share on Social Networks: